CALCIFICATION OF ATHEROSCLEROTIC PLAQUES AND OSTEOGENIC SIGNALING PATHWAYS

Authors

  • Toirova Shahrizoda Sherzod qizi Author

Keywords:

atherosclerosis, plaque calcification, vascular smooth muscle cells, osteogenic differentiation, RUNX2, BMP/SMAD, Wnt/β-catenin, inflammation, oxidative stress.

Abstract

Atherosclerotic plaque calcification is a complex and actively regulated process involved in the progression and structural remodeling of atherosclerotic lesions. Current evidence indicates that vascular calcification is not merely a passive consequence of tissue degeneration but involves coordinated cellular and molecular mechanisms. Vascular smooth muscle cells (VSMCs) play a central role by undergoing osteogenic and chondrogenic phenotypic transformation, associated with activation of the BMP/SMAD/RUNX2 and Wnt/β-catenin signaling pathways. Chronic inflammation, oxidative stress, extracellular matrix remodeling, and disturbances in mineral metabolism further promote osteogenic transformation and calcium-phosphate deposition. The biological effects of calcification depend on its morphology, size, and distribution within the plaque. Microcalcifications may increase local mechanical stress and contribute to plaque vulnerability, whereas larger consolidated calcifications may exert different structural effects. This review summarizes the current understanding of atherosclerotic plaque calcification, focusing on VSMC osteogenic transformation and major osteogenic signaling pathways.

References

1. Che. doi:10.1007/s11914-015-0293-9. PMID:26409849.

2. Leopold JA. Vascular calcification: mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med. 2015

25(4):267-274. doi:10.1016/j.tcm.2014.10.021. PMID:25435520.

3. Durham AL, Speer MY, Scatena M, Giachelli CM, Shanahan CM. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovasc Res. 2018

114(4):590-600. doi:10.1093/cvr/cvy010. PMID:29514202.

4. Tyson J, Bundy K, Roach C, Douglas H, Ventura V, Segars MF, et al. Mechanisms of the osteogenic switch of smooth muscle cells in vascular calcification: WNT signaling, BMPs, mechanotransduction, and EndMT. Bioengineering (Basel). 2020

7(3):88. doi:10.3390/bioengineering7030088. PMID:32781528.

5. Chen Y, Zhao X, Wu H. Transcriptional programming in arteriosclerotic disease: a multifaceted function of the Runx2 (Runt-related transcription factor 2). Arterioscler Thromb Vasc Biol. 2021

41(1):20-34. doi:10.1161/ATVBAHA.120.313791. PMID:33115268.

6. Li X, Yang HY, Giachelli CM. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis. 2008

199(2):271-277. doi:10.1016/j.atherosclerosis.2007.11.031. PMID:18179800.

7. Cai T, Sun D, Duan Y, Wen P, Dai C, Yang J, et al. WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression. Exp Cell Res. 2016

345(2):206-217. doi:10.1016/j.yexcr.2016.06.007. PMID:27321958.

8. Rong S, Zhao X, Jin X, Zhang Z, Chen L, Zhu Y, et al. Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the Wnt/β-catenin pathway. Cell Physiol Biochem. 2014

34(6):2049-2060. doi:10.1159/000366400. PMID:25562153.

9. Bundy K, Boone J, Simpson CL. Wnt signaling in vascular calcification. Front Cardiovasc Med. 2021

8:708470. doi:10.3389/fcvm.2021.708470. PMID:34595218.

10. Reinhold S, Blankesteijn WM, Foulquier S. The interplay of WNT and PPARγ signaling in vascular calcification. Cells. 2020

9(12):2658. doi:10.3390/cells9122658. PMID:33322009.

11. Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 2008

283(22):15319-15327. doi:10.1074/jbc.M800021200. PMID:18378684.

12. Liu Y, Shanahan CM. Signalling pathways and vascular calcification. Front Biosci (Landmark Ed). 2011

16(4):1302-1314. doi:10.2741/3790. PMID:21196233.

13. Wang D, Zhang X, Li Y, et al. Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting progressive ankylosis protein homolog expression. [Journal details should be retained according to the final PubMed record used for citation]. PMID: available through PubMed record.

14. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 2000

87(10):e10-e17. PMID:11090552.

15. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004

15(11):2857-2867. PMID:15504939.

16. Liu Y, Drozdov I, Shroff R, Beltran LE, Shanahan CM. Prelamin A accelerates vascular calcification via activation of the DNA damage response and inhibition of autophagy. Circ Res. 2013

113(8):e1-e12. [Use only if this mechanism is retained in the final text].

17. Wang M, et al. Vascular calcification is coupled with phenotypic conversion of vascular smooth muscle cells through Klf5-mediated transactivation of the Runx2 promoter. Biosci Rep. 2014

34(4):e00103. doi:10.1042/BSR20140103. PMID:25205373.

18. Augstein A, Mierke J, Poitz DM, Strasser RH. Sox9 is increased in arterial plaque and stenosis, associated with synthetic phenotype of vascular smooth muscle cells and causes alterations in extracellular matrix and calcification. Biochim Biophys Acta Mol Basis Dis. 2018

1864(8):2526-2537. doi:10.1016/j.bbadis.2018.05.009. PMID:29777903.

19. Shioi A, Mori K, Jono S, Koyama H, Hosoi M, Nishizawa Y. Mechanism of atherosclerotic calcification. J Atheroscler Thromb. 2006

13(6):278-285. [Use as background for osteogenic and mineralization mechanisms].

20. Shioi A, Ikari Y. Cardiovascular calcification during atherosclerosis and chronic kidney disease. J Atheroscler Thromb. 2018

25(4):256-263. [Use for clinical/pathophysiological background where appropriate].

21. Lin ME, Chen TM, Wallingford MC, Nguyen NB, Yamada S, Sawangmake C, et al. Runx2 deletion in smooth muscle cells protects against vascular calcification. Circ Res. 2016

119(10):1062-1074. [Use for the functional role of VSMC-derived RUNX2].

22. Hosaka N, Mizobuchi M, Ogata H, Kumata C, Kondo F, Koiwa F, et al. Inhibition of bone morphogenetic protein signaling suppresses vascular calcification in chronic kidney disease. [Verify final bibliographic details before submission].

23. Shioi A, Morioka T, Shoji T, Emoto M. The inhibitory roles of vitamin K in progression of vascular calcification. Nutrients. 2020

12(2):583. doi:10.3390/nu12020583.

24. Maldonado N, Kelly-Arnold A, Vengrenyuk Y, Laudier D, Fallon JT, Virmani R, et al. A mechanistic analysis of the role of microcalcifications in atherosclerotic plaque stability: potential implications for plaque rupture. Am J Physiol Heart Circ Physiol. 2012

303(5):H619-H628. doi:10.1152/ajpheart.00036.2012. PMID:22777419.

25. Zhao Y, Li H, Guo Y. Interleukin family in vascular calcification: molecular mechanisms and therapeutic perspectives. Front Cardiovasc Med. 2025

12:1619018. doi:10.3389/fcvm.2025.1619018. PMID:40959491.

Published

2026-10-02